At the Beacon Angels meeting on April 9, 2024, we entertained new funding presentations as follows:
- AGED Diagnostics (Rachel Zayas – a pre-clinical diagnostics venture developing blood tests for fatty liver disease and liver fibrosis.
- Vuja De Sciences – providing a novel approach to prevent cancer recurrence and progression.
- PneumoNIX Medical – offering a product to eliminate complications of tissue biopsy by sealing the biopsy track at the outset.
Members reported on companies in due diligence:
- Surgicure Technologies,
- Glycologix,
- Agile Devices &
- AI Lean.
Beacon Angels 